Aldeyra Therapeutics Inc. (ALDX)
NASDAQ: ALDX
· Real-Time Price · USD
5.74
0.42 (7.89%)
At close: Oct 03, 2025, 3:59 PM
5.62
-2.09%
After-hours: Oct 03, 2025, 07:56 PM EDT
Aldeyra Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 41.24M | 50.35M | 54.53M | 68.12M | 71.03M | 102.49M | 142.82M | 143.33M | 151.68M | 165.03M | 144.42M | 128.65M | 121.01M | 158.91M | 229.79M | 241.37M | 249.74M | 138.44M |
Short-Term Investments | 40.68M | 39.71M | 46.62M | 44.62M | 49.3M | 30.55M | n/a | n/a | n/a | n/a | 29.88M | 56.68M | 75.68M | 57.96M | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | 267.26K | 267.26K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Receivables | n/a | 755.54K | n/a | 40M | n/a | n/a | n/a | n/a | n/a | 23.68K | 3.24M | n/a | n/a | n/a | 28.77K | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 1.61M | 1.77M | 2.51M | -37.17M | 4.28M | 7.68M | 4.65M | 3.27M | 2.93M | 2.81M | 3.05M | 3.39M | 2.96M | 5.06M | 2.5M | 4.53M | 5.22M | 8.41M |
Total Current Assets | 84.56M | 92.73M | 104.07M | 116.72M | 125.65M | 140.85M | 147.81M | 147.21M | 155.48M | 168.02M | 181.02M | 189.48M | 200.74M | 222.36M | 232.75M | 246.77M | 256.26M | 147.07M |
Property-Plant & Equipment | 404.66K | 466.94K | 266.95K | 331.33K | 394.31K | 455.95K | 516.58K | 72.23K | 137.23K | 201.57K | 268.54K | 208.6K | 273.91K | 337.93K | 384.35K | 445.62K | 166.48K | 233.18K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 404.66K | 466.94K | 534.22K | 598.59K | 394.31K | 455.95K | 516.58K | 72.23K | 137.23K | 201.57K | 268.54K | 208.6K | 273.91K | 337.93K | 384.35K | 445.62K | 166.48K | 233.18K |
Total Assets | 84.96M | 93.2M | 104.61M | 117.32M | 126.04M | 141.3M | 148.33M | 147.28M | 155.62M | 168.22M | 181.29M | 189.69M | 201.02M | 222.69M | 233.14M | 247.22M | 256.43M | 147.31M |
Account Payables | 1.46M | 346.15K | 180.45K | 186.92K | 254.43K | 280.3K | 1.34M | 247.19K | 270.82K | 429.69K | 133.63K | 1.31M | 264.23K | 2.44M | 1.02M | 467.93K | 1.09M | 448.59K |
Deferred Revenue | 6M | 6M | 6M | 6M | 6M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 15.15M | 255.34K | 31.37K | 279.96K | 15.24M | 15.2M | 15.15M | 13.46M | 5.89M | 954.33K | 911.76K | 12.45M | 4.93M | n/a | n/a | n/a | n/a | 5.09M |
Other Current Liabilities | 3.16M | 4.01M | 4.33M | 4.28M | 2.57M | 2.91M | 3.09M | 5.24M | 5.8M | 5.51M | 3.82M | 2.23M | 1.24M | 1.08M | 1.51M | 2.08M | 2.17M | 2.39M |
Total Current Liabilities | 29.53M | 14.29M | 18.6M | 17.15M | 27.59M | 21.68M | 22.26M | 21.62M | 15.61M | 16.01M | 15.36M | 24.2M | 16.24M | 16.35M | 11.77M | 11.94M | 7.41M | 11.09M |
Long-Term Debt | n/a | 15.1M | 15M | 15M | n/a | n/a | n/a | 2.66M | 10.13M | 14.97M | 14.92M | 3.3M | 10.74M | 15.59M | 15.5M | 15.42M | 15.34M | 10.14M |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 143.45K | 15.31M | 15M | 15.07M | 138.89K | 6.21M | 6.27M | 2.66M | 10.13M | 14.97M | 14.92M | 3.3M | 10.74M | 15.65M | 15.63M | 15.61M | 15.34M | 10.14M |
Total Liabilities | 29.67M | 29.6M | 33.6M | 32.22M | 27.73M | 27.88M | 28.53M | 24.27M | 25.73M | 30.98M | 30.28M | 27.5M | 26.99M | 32M | 27.4M | 27.55M | 22.75M | 21.23M |
Total Debt | 15.56M | 15.57M | 15.3M | 15.61M | 15.64M | 15.66M | 15.66M | 16.18M | 16.15M | 16.11M | 16.08M | 15.94M | 15.91M | 15.89M | 15.86M | 15.83M | 15.46M | 15.41M |
Book Value | 55.29M | 63.6M | 71M | 85.1M | 98.31M | 113.42M | 119.8M | 123.01M | 129.88M | 137.24M | 151.01M | 162.19M | 174.03M | 190.69M | 205.74M | 219.67M | 233.68M | 126.07M |
Book Value Per Share | 0.92 | 1.06 | 1.19 | 1.43 | 1.65 | 1.91 | 2.02 | 2.09 | 2.21 | 2.33 | 2.58 | 2.77 | 2.99 | 3.27 | 3.55 | 3.79 | 4.31 | 2.76 |
Common Stock | 60.05K | 60.05K | 59.65K | 59.55K | 59.41K | 59.41K | 59.2K | 59.19K | 58.8K | 58.79K | 58.56K | 58.56K | 58.3K | 58.3K | 58.08K | 58.05K | 58K | 47.65K |
Retained Earnings | -469.81M | -460.04M | -450.11M | -434.3M | -419.19M | -402.34M | -394.26M | -389.51M | -381.32M | -372.33M | -356.72M | -343.81M | -329.26M | -311.48M | -294.69M | -278.94M | -263.14M | -248.21M |
Comprehensive Income | -10.99K | 1.6K | 37.44K | 66.54K | -9.66K | -3.03K | n/a | n/a | n/a | n/a | -103.94K | -285.73K | -285.76K | -61.68K | n/a | n/a | n/a | n/a |
Shareholders Equity | 55.29M | 63.6M | 71M | 85.1M | 98.31M | 113.42M | 119.8M | 123.01M | 129.88M | 137.24M | 151.01M | 162.19M | 174.03M | 190.69M | 205.74M | 219.67M | 233.68M | 126.07M |
Total Investments | 40.68M | 39.71M | 46.62M | 44.62M | 49.3M | 30.55M | n/a | n/a | n/a | n/a | 29.88M | 56.68M | 75.68M | 57.96M | n/a | n/a | n/a | n/a |